CONTINUE TO SITE ➞

Don't miss tomorrow's biopharma industry news

Let BioPharma Dive's free newsletter keep you informed, straight from your inbox.

Daily Dive M-F

Commercialization Weekly Every Wednesday

Gene Therapy Weekly Every Thursday

Emerging Biotech Weekly Every Tuesday

By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

Deep Dive
Library
Events
Press Releases

Pharma
Biotech
FDA
Clinical Trials
Deals
Drug Pricing
Gene Therapy

What We're Reading: Page 21

Industry reads hand-picked by our editors

Jun 27, 2025

Reuters
Meet the Americans who make their own weight-loss drugs
FierceBiotech
Gilead blames low infection rates for ending 2 RSV trials
Bloomberg
WeightWatchers Customers Now Have Access to Wegovy at a Cheaper Price

Jun 26, 2025

MIT Technology Review
Google’s new AI will help researchers understand how our genes work
BioSpace
Longevity Biotech Takes Root on Nasdaq With $180M SPAC Deal
Politico
RFK Jr. says US won’t donate to global vaccine effort

Jun 25, 2025

Endpoints News
FDA’s Makary sought rejection of KalVista’s drug in an unusual move by commissioner, sources say
CNN
Presentation for CDC advisers appears to cite nonexistent study to support claims about risk of vaccine preservative
Stat News
Top FDA drug regulator tells staff much is still in flux, as she prepares to retire
Fierce Biotech
Bayer-owned BlueRock lays off 50 employees, shuts Cambridge research labs

Jun 24, 2025

Nikkei
Chinese biotech is having a ‘DeepSeek moment’
The Wall Street Journal
How Weight-Loss Drugs Blew Out the U.S. Trade Deficit
NBC News
Outside groups organize to form unbiased, independent vaccine panel
Axios
NIH grantees may face long waits for restored money

Jun 23, 2025

The New York Times
People With Severe Diabetes Are Cured in Small Trial of New Drug
Science News
Always ‘one atom away’: The long, rocky journey to an HIV prevention breakthrough
FirstWord Pharma
Otsuka signs $670M deal with Harbour for BCMAxCD3 bispecific

Jun 20, 2025

The New York Times
Why a Vaccine Expert Left the C.D.C.: ‘Americans Are Going to Die’
Nature
AI slashes time to produce gold-standard medical reviews — but sceptics urge caution
BioCentury
Amarin, Merck alum Karim Mikhail emerges as possible head of FDA’s CDER

Jun 18, 2025

The Wall Street Journal
Generic Drugmakers Resist Trump’s Calls for More U.S. Manufacturing
KFF Health News
A Revolutionary Drug for Extreme Hunger Offers Clues to Obesity’s Complexity
Reuters
US Senate Democrats demand Kennedy explain canceling bird flu vaccine contract

Previous Next

Get the free newsletter

Subscribe to BioPharma Dive for top news, trends & analysis

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.

Library resources

Webinar - on demand
AI Transformation Across Pharmacovigilance Custom content for PPD, part of Thermo Fisher Scientific
Trendline
The future of neuroscience drug development Supported by Catalent
Trendline
The latest developments in oncology research Supported by Premier Research International LLC

View all

Company Announcements

View all | Post a press release

Events

View all | Promote an event

Industry Intel

Top Ways that AI Will Change Life Sciences Webinar - on demand • Provided by Salesforce
Revolutionizing Next Generation Gene Therapies with On-Demand Large DNA Construct Synthesis and Novel, Designable Delivery Vehicles Webinar - on demand • Provided by Ansa Biotechnologies
Developing an Array of Diverse Vaccine Platforms Webinar - on demand • Provided by BioPharma Dive's studioID; Sponsored content by Novavax in partnership with studioID

Explore

About
Editorial Team
Contact Us
Newsletter
Purchase Licensing Rights
Press Releases
What We're Reading

Reach our audience

Advertising
Post a press release
Promote an event

Related Publications

Healthcare Dive
MedTech Dive
PharmaVoice
Xtelligent Pharma Life Sciences

Industry Dive is an Informa TechTarget business.

This website is owned and operated by Informa TechTarget, part of a global network that informs, influences and connects the world's technology buyers and sellers. All copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. TechTarget, Inc.'s registered office is 275 Grove St. Newton, MA 02466.

Home
- Pharma
- Biotech
- FDA
- Clinical Trials
- Deals
- Drug Pricing
- Gene Therapy
Deep Dive
Library
Events
Press Releases

Get BioPharma Dive in your inbox

The free newsletter covering the top industry headlines

Email:

Select Newsletter: Daily Dive M-F
Select Newsletter: Commercialization Weekly Every Wednesday
Select Newsletter: Gene Therapy Weekly Every Thursday
Select Newsletter: Emerging Biotech Weekly Every Tuesday
Select user consent: By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime.

A valid email address is required. Please select at least one newsletter.